rfhg_27596.1

Basic information about the TSS

---

TSS ID: rfhg_27596.1 Species: human Chr: chr2		Start: 68252669 End: 68252679 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3136319,EH38E2006305)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000234310.8:137 GeneID: 5534 HGNC/MGI_ID: HGNC:9317 UniProt_ID: P63098 Nearer transcript ids and distances:

Gene_name: PPP3R1 Gene_symbol: PPP3R1 Gene_synonyms: CALNB1 CNB CNB1 Gene_source: HGNC:9317

TATA-Box annotation

---

Distance to TSS:	-142
Nearest PromoterID:	NM_000945
Entrez ID:	5534
Nearest Unigene:	Hs.280604
Nearest Refseq:	NM_000945
Nearest Ensembl:	ENSG00000221823
Gene Name:	PPP3R1
Gene Alias:	CALNB1|CNB|CNB1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.545455
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PPP3R1 p2@PPP3R1 p3@PPP3R1 p4@PPP3R1 p7@PPP3R1
Sample		p1@PPP3R1	p2@PPP3R1	p3@PPP3R1	p4@PPP3R1	p7@PPP3R1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	73.83	0.78	2.53	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	79.11	0.81	3.84	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	85.26	0.77	2.51	0.39	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	71.11	1.04	3.33	0.62	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	69.51	1.12	3.37	0.22	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	64.54	1.55	2.13	0.19	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	73.64	1.31	3.70	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	58.86	1.21	1.94	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	74.59	0.85	2.56	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	71.29	2.90	4.06	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	63.06	4.04	6.87	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	93.51	2.85	5.29	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	54.97	2.90	0.64	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	39.84	3.31	0.15	0.90	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	51.60	1.10	0.22	0.88	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	46.53	1.26	0.00	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	42.15	2.18	0.22	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	29.53	2.11	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	39.99	1.07	0.00	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	37.91	0.75	0.75	0.45	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	38.76	1.87	0.67	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.67	1.55	1.38	0.86	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	37.61	1.68	0.13	0.39	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	45.86	1.70	0.49	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	54.18	2.06	0.52	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.35	1.90	0.63	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	41.76	0.55	1.65	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	51.87	2.59	1.41	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	45.39	0.81	0.81	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	51.21	1.99	1.09	0.36	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	41.66	1.47	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.02	2.15	1.17	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	35.87	0.42	1.69	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.41	1.65	1.15	0.66	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	48.80	1.50	1.87	0.19	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	60.74	2.30	0.00	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	54.16	1.84	0.61	0.41	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	42.11	0.60	0.81	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.27	2.43	0.27	1.08	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	45.13	1.68	0.72	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	46.58	1.41	0.94	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	38.21	1.32	1.02	0.59	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	47.66	1.27	1.48	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	50.35	2.27	0.87	0.70	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	58.63	2.01	1.61	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.13	2.56	0.93	1.40	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	55.42	2.40	1.20	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	46.50	1.19	2.98	1.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	63.67	3.11	1.68	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	58.23	3.44	1.82	1.42	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	57.59	2.25	1.43	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	65.38	3.34	2.00	1.33	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	45.07	1.42	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	48.38	1.99	0.66	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	56.21	2.52	2.52	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	42.71	2.76	0.92	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	55.42	2.92	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	68.09	2.25	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	79.21	3.46	0.00	1.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	32.43	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	37.57	2.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	101.91	7.17	3.18	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	60.14	3.06	2.38	1.36	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	64.33	1.95	1.95	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	59.28	3.55	1.06	1.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	42.90	0.98	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	57.03	0.99	0.99	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	65.21	1.41	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	122.21	2.32	0.33	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	67.75	1.24	0.31	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	69.40	1.22	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	41.02	1.43	0.95	0.79	0.16
Adipocyte - breast, donor2	11327-117E4	35.78	0.96	0.48	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	60.56	1.65	1.02	0.13	0.64
Adipocyte - omental, donor2	11474-119C7	19.43	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	35.17	1.00	1.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	30.62	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	32.07	1.81	1.81	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	18.42	0.87	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	71.77	1.56	0.59	0.78	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	56.37	0.26	0.77	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	46.00	0.56	0.56	1.95	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	60.54	1.18	0.00	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	85.02	1.93	0.88	0.32	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	58.10	1.29	0.97	0.00	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	43.72	0.00	0.53	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	51.75	1.67	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	44.08	2.08	1.25	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	38.18	0.25	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	41.89	0.65	1.96	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	55.41	2.74	0.61	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	42.43	1.55	0.66	0.88	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	9.32	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	2.40	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	24.29	1.08	1.26	0.54	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.48	1.23	0.82	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	35.82	1.72	0.57	0.23	0.34
Anulus Pulposus Cell, donor2	11463-119B5	31.59	1.71	0.24	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	33.25	0.00	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	33.86	0.43	0.43	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	0.00	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.31	0.60	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	0.00	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.34	0.97	0.65	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	29.13	1.46	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	1.78	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	31.64	1.51	0.75	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	21.04	1.45	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	35.58	0.49	1.32	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	31.52	1.21	0.75	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.25	0.00	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.90	1.89	0.76	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	32.07	0.53	0.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	24.39	0.98	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.35	1.00	0.50	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	14.41	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	24.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	37.05	1.20	0.86	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.10	0.97	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.77	0.76	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	2.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	25.65	0.57	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	31.42	1.07	0.64	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.20	0.77	0.26	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.40	1.29	0.96	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.81	0.58	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	29.20	0.60	0.60	1.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	35.64	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	27.46	1.02	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	27.00	1.02	0.00	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.33	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	0.86	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	31.33	1.27	1.06	0.85	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.39	0.87	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.96	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.67	0.34	0.51	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	27.46	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	29.37	1.07	0.64	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	26.47	0.60	0.60	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	26.21	0.92	1.15	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	39.41	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.89	0.62	0.62	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	29.07	0.31	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	40.63	0.00	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	29.71	0.89	1.11	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.69	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	34.42	0.26	0.53	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	32.35	0.00	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	35.62	2.09	0.86	1.60	0.00
Astrocyte - cerebellum, donor2	11580-120F5	38.85	2.05	0.17	1.37	0.00
Astrocyte - cerebellum, donor3	11661-122F5	20.76	0.84	0.21	0.42	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	41.83	2.79	0.70	1.05	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	53.39	2.91	0.49	0.32	0.32
Astrocyte - cerebral cortex, donor3	11392-118C6	54.74	2.98	1.19	1.04	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	76.04	3.78	1.83	1.03	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	76.17	4.76	2.26	1.38	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	80.57	4.21	2.62	1.37	0.68
Basophils, donor1	12241-129G9	102.00	1.31	3.92	0.00	0.78
Basophils, donor2	12242-129H1	125.56	2.89	5.41	1.80	0.36
Basophils, donor3	12243-129H2	104.22	1.62	3.23	0.29	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	22.42	0.43	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	10.97	1.83	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	37.03	2.51	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	36.18	1.87	0.21	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	26.94	1.38	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.73	1.44	0.54	0.72	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.60	4.23	1.44	2.16	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	88.50	5.82	1.40	3.03	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	78.66	4.80	2.24	1.28	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	75.52	1.13	5.64	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	131.96	1.86	5.20	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	95.28	1.54	4.39	1.76	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	221.34	2.83	6.51	0.28	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	156.18	2.27	3.41	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	257.40	6.25	8.88	2.30	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	97.28	3.04	5.49	0.87	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	103.80	2.11	3.32	0.91	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	139.06	2.61	6.16	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	69.97	1.34	5.86	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	120.62	1.66	9.11	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	117.52	0.25	9.17	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	118.26	2.94	9.79	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	184.64	1.07	8.19	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	165.62	0.65	11.10	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	81.24	1.17	6.56	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	179.53	0.53	11.09	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	125.36	0.00	5.55	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	55.19	2.08	3.72	1.04	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	82.21	0.60	4.39	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	74.74	0.21	7.50	0.42	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	82.36	3.20	4.80	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	141.15	1.13	10.86	1.36	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	113.92	2.18	8.29	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	132.34	4.30	5.11	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	179.35	2.97	8.37	0.70	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	172.96	2.95	10.94	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	60.44	1.29	5.70	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	103.92	0.70	9.86	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	106.61	0.44	9.65	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	117.18	1.39	8.02	0.35	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	186.95	1.12	11.52	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	181.92	1.08	14.23	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	61.01	0.82	4.09	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	110.34	1.85	10.89	0.23	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	89.55	1.39	6.96	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	65.61	1.09	1.31	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	98.40	0.69	1.62	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	44.19	0.43	1.73	2.17	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	120.22	2.96	4.05	0.93	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	118.06	1.92	2.62	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	167.67	4.91	5.13	2.23	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	78.08	1.28	2.55	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	101.88	0.88	1.32	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	65.48	2.11	1.05	1.26	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	69.10	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	73.90	8.14	3.39	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	74.56	6.21	3.11	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	89.02	4.26	1.60	2.67	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	89.52	6.43	3.75	5.36	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	87.74	4.91	0.70	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	67.45	4.71	1.57	2.35	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	61.96	9.23	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	140.54	5.75	8.22	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	101.56	2.90	2.90	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	124.19	2.02	2.52	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	277.99	6.87	17.78	1.21	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	208.53	4.39	11.59	0.00	2.00
CD34+ Progenitors, donor1	11545-120B6	82.33	0.00	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	111.24	3.93	3.93	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	58.99	4.13	2.25	1.88	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	83.65	4.74	2.71	3.16	0.23
CD4+ T Cells, donor1	11225-116C1	83.91	10.35	5.00	4.28	1.79
CD4+ T Cells, donor2	11306-117C1	115.74	10.41	3.67	1.22	1.84
CD4+ T Cells, donor3	11382-118B5	110.41	9.45	5.49	1.83	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	67.38	4.08	1.02	1.79	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	93.66	2.70	2.25	0.22	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	67.55	6.61	0.86	2.59	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	67.80	3.32	1.42	2.37	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	92.00	2.81	1.40	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	39.55	6.59	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	76.02	3.03	1.45	2.17	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	110.66	5.08	1.69	0.85	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	69.00	6.45	0.64	2.90	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	59.18	2.24	0.90	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	72.32	2.10	2.10	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	47.96	3.08	3.96	2.64	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	57.34	2.53	1.26	1.26	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	101.18	6.23	1.66	0.42	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	69.50	4.01	2.00	2.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	85.66	5.17	3.81	2.99	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	115.77	3.22	2.14	1.07	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	5.38	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	93.83	3.52	1.30	0.56	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	92.28	3.03	1.52	0.22	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	89.31	5.46	0.84	2.73	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	66.23	3.54	3.03	2.53	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	78.42	4.33	2.17	0.87	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	75.40	2.18	3.05	3.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	72.25	6.93	1.98	3.46	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	3.69	0.92	4.62	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	4.19	2.79	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	91.39	6.37	2.77	4.43	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	76.07	8.10	2.70	6.87	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	70.84	6.16	3.08	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	80.93	7.88	5.01	1.79	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	59.55	5.54	0.00	4.15	0.00
CD8+ T Cells, donor1	11226-116C2	95.27	4.26	5.24	3.27	0.33
CD8+ T Cells, donor2	11307-117C2	114.13	3.75	4.88	1.50	0.38
CD8+ T Cells, donor3	11383-118B6	106.30	6.31	5.81	2.78	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	53.68	0.46	1.15	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	57.27	1.68	0.96	0.72	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	52.80	1.37	0.55	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	51.64	2.70	3.00	2.40	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	52.80	1.68	1.44	0.48	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	63.67	2.05	1.59	1.82	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	54.32	1.30	1.09	1.30	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	53.69	2.11	0.79	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	59.10	1.41	1.64	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	59.77	2.11	0.30	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	64.49	2.03	1.74	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	70.87	2.13	0.80	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	94.55	1.31	2.63	2.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	93.82	0.91	1.37	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	169.31	4.48	4.48	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	52.94	1.44	1.80	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	61.28	1.44	2.59	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	58.22	1.41	1.65	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	59.58	1.27	2.54	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	72.28	1.85	1.54	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	53.22	2.24	1.28	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	61.19	0.38	1.15	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.15	1.58	1.97	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	46.90	0.76	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	93.95	0.80	2.41	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	115.41	0.70	2.10	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	82.14	0.00	3.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	69.45	5.48	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	25.69	0.00	0.49	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	35.57	1.58	0.42	1.37	0.11
Chondrocyte - de diff, donor1	11261-116G1	57.89	1.04	1.04	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	30.56	0.36	0.71	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	29.70	0.91	0.91	0.68	0.23
Chondrocyte - re diff, donor2	11339-117F7	59.09	1.79	2.69	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	39.63	2.02	1.62	1.21	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	48.08	4.02	0.69	0.92	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	49.38	1.28	1.50	0.64	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	49.29	3.27	0.53	0.44	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	105.18	6.42	3.67	1.74	1.01
Corneal Epithelial Cells, donor1	11526-119I5	16.69	0.44	0.44	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	22.75	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	30.16	1.53	0.26	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	54.98	3.47	1.82	0.83	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	53.94	3.15	1.89	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	49.57	1.40	1.30	1.19	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	139.05	11.27	5.81	4.10	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	103.15	6.53	1.96	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	103.56	11.13	4.84	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	40.52	1.50	1.33	0.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	29.34	1.17	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	49.77	1.70	1.13	0.57	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	59.76	1.97	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	35.20	1.16	0.29	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	43.76	0.94	1.41	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	44.00	2.45	0.88	0.70	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.89	1.77	1.33	0.89	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	55.07	2.43	0.91	1.52	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	61.74	1.41	1.69	0.56	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	29.42	0.59	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	28.64	1.04	2.60	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	28.92	1.13	1.42	0.57	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	80.02	2.00	2.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	34.59	1.57	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	82.50	4.10	1.12	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	81.47	3.26	1.09	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	80.60	4.64	0.85	1.83	0.37
Endothelial Cells - Vein, donor1	11267-116G7	25.03	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	26.54	0.70	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	38.31	0.63	0.31	0.16	0.00
Eosinophils, donor1	12244-129H3	228.70	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	470.32	13.20	44.56	1.65	0.00
Eosinophils, donor3	12246-129H5	353.12	7.13	28.53	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	25.65	0.49	0.98	0.73	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	78.41	1.23	1.64	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	37.88	0.99	0.33	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	50.81	2.93	1.73	2.06	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	45.84	2.30	1.33	0.61	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	51.59	0.82	0.55	0.55	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	50.20	0.95	0.74	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	35.31	1.58	0.00	1.05	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	50.83	0.66	0.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	53.98	0.91	0.45	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	34.87	0.00	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	23.03	0.95	1.26	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	77.60	2.73	2.12	0.91	0.91
Fibroblast - Cardiac, donor5	11456-119A7	50.13	1.90	0.51	0.89	0.38
Fibroblast - Cardiac, donor6	11460-119B2	57.61	1.67	0.61	0.61	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	47.43	1.74	0.27	0.80	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	51.34	1.29	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	0.00	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	53.28	1.85	1.15	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	42.74	1.53	0.00	0.51	0.00
Fibroblast - Dermal, donor1	11269-116G9	39.68	1.17	1.64	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	37.26	1.89	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	40.50	1.69	0.73	0.00	0.36
Fibroblast - Dermal, donor4	11450-119A1	58.11	2.83	0.79	0.45	0.34
Fibroblast - Dermal, donor5	11454-119A5	71.18	2.09	0.52	0.35	0.52
Fibroblast - Dermal, donor6	11458-119A9	81.54	2.11	0.81	0.49	0.00
Fibroblast - Gingival, donor1	11237-116D4	47.06	0.21	0.42	0.83	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	83.84	4.72	0.79	1.05	1.05
Fibroblast - Gingival, donor2	11318-117D4	51.66	1.58	0.00	0.13	0.26
Fibroblast - Gingival, donor3	11394-118C8	60.53	1.26	0.77	0.39	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	68.57	4.16	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	55.86	1.94	0.88	1.59	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	88.39	2.18	1.09	0.16	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	83.57	1.22	1.35	0.41	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	290.77	8.12	7.06	1.76	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	101.49	3.22	1.46	0.00	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	74.04	1.91	1.36	0.68	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	136.57	4.72	1.65	1.43	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	120.77	4.11	3.37	2.64	0.00
Fibroblast - Lung, donor1	11270-116H1	24.47	0.00	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	50.73	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	44.11	1.27	0.21	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	47.48	3.33	0.00	1.67	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	50.35	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	17.63	0.84	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	89.72	3.25	0.81	2.44	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	11.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	53.73	1.75	0.58	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	72.66	4.25	0.76	1.21	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	90.27	0.92	0.92	0.92	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	83.58	2.29	0.38	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	62.37	1.89	0.81	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	69.70	2.32	1.16	1.62	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	41.34	1.77	0.55	0.77	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	72.95	1.42	1.02	0.81	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.07	2.67	0.67	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.98	0.40	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	34.93	2.58	0.20	1.59	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.18	0.36	1.07	1.42	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	41.78	0.39	0.20	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	32.19	1.20	0.00	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	54.08	1.73	0.32	0.22	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	40.24	0.51	0.25	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	42.82	0.33	0.98	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	57.35	1.20	1.00	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	43.20	2.61	1.21	0.90	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	37.78	1.21	0.30	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.67	1.16	1.41	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	42.91	1.71	1.03	0.85	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.44	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	46.87	1.92	0.85	0.43	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	52.12	0.51	1.01	0.17	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	37.17	2.67	1.73	0.31	0.94
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	85.41	0.87	2.61	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	42.65	0.87	1.04	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	62.20	0.52	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	75.38	2.04	3.32	0.26	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	87.27	9.19	1.53	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	65.72	5.74	0.64	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	98.13	11.13	2.28	3.71	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	121.88	5.24	1.10	4.41	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	86.99	3.42	1.83	2.28	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	109.76	7.93	2.77	3.57	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	119.74	7.40	0.26	1.85	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	77.95	4.57	0.65	1.96	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	112.77	6.19	1.77	3.54	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	37.31	1.55	0.42	2.54	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.96	2.83	0.37	0.86	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	42.98	2.95	0.27	2.69	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	44.35	2.48	0.74	1.12	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	45.96	2.49	0.42	2.21	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	39.03	3.25	1.42	1.83	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	40.62	2.05	0.68	0.68	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.11	1.74	0.50	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	47.43	4.81	0.44	1.75	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	40.19	0.89	0.30	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.81	1.75	0.79	1.27	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	41.78	1.56	0.89	1.12	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	37.30	2.22	1.21	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	41.73	1.36	0.51	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	55.95	1.42	1.33	1.33	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	59.62	2.08	0.94	2.08	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.77	1.02	0.34	1.88	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	47.36	1.44	0.44	0.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	43.59	1.75	0.92	0.92	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.53	1.63	0.61	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	34.25	1.03	0.62	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	41.39	1.50	1.04	0.92	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	41.69	1.00	0.50	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	39.46	2.65	0.22	1.54	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	46.61	1.84	0.98	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	39.71	0.81	0.97	1.46	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	46.82	1.92	0.96	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.09	1.14	0.28	0.85	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.02	1.11	0.79	0.63	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	41.66	1.52	0.61	1.22	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	39.31	1.57	0.42	0.52	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.23	0.66	0.66	1.54	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	38.44	2.81	1.12	1.40	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.29	1.30	0.37	0.74	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.52	1.07	1.34	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	54.93	1.99	0.61	0.61	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	46.89	1.81	0.13	0.78	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	47.71	0.81	1.08	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	45.90	1.11	1.47	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	35.75	1.54	0.66	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	95.21	4.96	0.00	4.96	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	46.04	1.71	1.32	0.92	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	41.76	0.81	0.61	1.82	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	113.61	5.85	5.34	4.07	1.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	38.22	4.18	0.40	2.79	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	35.59	3.08	0.15	1.69	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	50.53	3.07	0.82	2.25	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	46.94	5.63	0.63	1.25	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.40	1.70	0.85	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	63.19	2.31	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	74.27	2.71	0.39	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	101.08	1.60	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	6.96	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	72.26	3.25	0.33	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	65.06	3.29	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	83.31	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	77.74	1.96	0.28	0.28	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	68.64	2.61	1.63	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	55.36	3.36	2.52	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	84.93	2.23	0.64	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	74.05	3.40	1.02	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	69.30	2.29	1.72	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	50.91	1.18	0.30	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	55.91	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	56.75	2.07	0.83	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	57.99	1.84	0.92	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	50.74	0.00	1.15	0.38	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	57.70	0.98	0.98	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	67.55	1.34	0.67	1.34	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	63.95	0.77	0.00	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	112.63	3.08	2.05	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	104.36	9.94	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	86.35	0.94	1.42	1.89	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	62.76	3.62	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	88.51	1.02	0.51	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	74.18	2.79	0.80	1.20	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	64.63	1.97	0.00	0.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	69.65	2.36	3.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	55.43	1.17	1.17	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.39	2.19	0.44	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	92.40	0.85	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	45.96	0.60	0.60	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	33.48	0.49	0.97	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	46.79	2.28	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.86	0.83	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.54	1.90	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.22	0.84	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.92	2.55	1.16	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.14	2.19	0.51	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	45.73	0.68	0.46	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	39.46	0.77	0.66	0.77	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	51.79	2.36	1.07	0.21	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	43.70	1.08	0.86	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	39.60	0.62	1.37	0.50	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	37.23	1.20	0.69	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	36.52	1.60	0.96	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	65.48	2.80	0.56	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	39.82	0.43	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	34.92	1.76	0.35	0.35	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	36.33	2.18	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.22	2.80	1.22	0.70	0.00
Hepatocyte, donor1	11523-119I2	96.85	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	76.49	1.08	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	80.99	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	39.16	9.79	2.61	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	73.23	0.35	1.92	0.70	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.52	1.10	0.69	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	23.53	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	15.02	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	41.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	45.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	28.34	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	39.70	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	22.17	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	37.16	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	35.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	56.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	52.15	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	23.51	0.00	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	43.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	44.32	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	32.10	0.00	0.47	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	42.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	0.00	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	47.01	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	47.83	0.00	0.00	0.64	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	44.99	0.00	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.63	0.62	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	48.68	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	38.36	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	41.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	26.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	55.73	0.65	1.14	0.16	0.24
Keratinocyte - epidermal, donor2	11349-117G8	21.67	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	54.52	2.37	0.47	0.57	0.19
Keratinocyte - oral, donor1	11251-116E9	53.69	2.27	0.79	0.79	0.11
Keratocytes, donor1	11527-119I6	56.39	0.34	0.34	0.34	0.00
Keratocytes, donor2	11607-120I5	25.78	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	41.89	1.19	0.99	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	92.31	4.40	10.99	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	28.05	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	25.49	0.81	0.00	1.04	0.12
Lens Epithelial Cells, donor3	11690-122I7	51.26	3.73	1.11	1.41	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	40.32	1.54	1.19	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.84	0.00	0.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.88	1.10	0.63	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.05	1.61	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	28.36	0.95	0.32	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	20.59	0.65	0.11	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	33.24	0.41	0.41	0.00	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.18	0.25	0.51	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.56	0.56	0.28	1.13	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	32.43	2.37	1.98	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.25	0.78	0.19	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.70	1.11	0.37	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	35.19	0.35	1.05	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.71	1.19	1.19	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	21.84	1.10	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	33.26	0.92	0.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.40	0.62	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.31	1.28	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	29.62	0.99	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.64	0.88	0.00	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	15.18	0.50	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	31.04	0.48	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	37.70	0.54	0.81	0.00	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	26.95	1.21	0.15	1.06	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	21.25	0.00	1.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	39.16	0.84	0.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.52	1.35	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	35.08	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	31.23	0.75	0.38	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.18	1.17	0.11	0.11	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	37.80	1.45	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	28.12	1.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.19	0.62	0.62	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.72	0.37	1.11	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	30.89	0.99	0.49	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	19.80	0.69	0.55	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	32.49	0.64	0.32	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	42.00	0.61	1.52	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.29	1.54	0.42	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	33.07	1.07	1.42	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	23.27	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.92	0.47	0.62	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	25.43	1.43	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	31.69	0.00	0.98	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.30	0.94	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.69	0.99	1.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.26	0.00	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.18	1.19	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	58.30	2.30	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	37.85	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	49.51	2.12	0.42	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	46.42	1.41	0.00	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	35.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	51.53	1.55	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	49.96	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	47.05	1.36	0.68	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	51.77	1.45	0.87	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	64.37	1.80	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	63.14	1.08	1.49	0.14	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	66.76	2.05	2.05	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	53.63	1.06	1.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	41.31	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	76.92	1.53	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	60.30	1.07	1.07	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	68.02	1.32	0.94	0.19	1.51
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	67.49	1.23	1.23	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	79.10	1.63	3.26	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	62.68	1.67	1.04	0.21	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	70.63	2.80	1.96	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	80.37	0.00	4.12	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	70.25	2.03	1.45	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	63.37	0.60	2.09	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	63.62	0.55	2.21	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	81.66	2.47	2.47	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	64.54	1.48	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	57.56	0.00	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	72.53	3.45	1.54	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	61.71	2.83	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	63.18	1.64	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	71.40	0.45	3.16	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	71.10	0.72	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	74.69	2.24	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	67.63	1.11	1.49	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	60.74	0.43	0.86	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	68.50	3.43	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	62.97	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	65.76	1.21	1.21	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	56.17	1.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	60.49	1.03	1.03	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	49.38	0.54	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	60.60	4.04	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	68.16	2.59	1.11	0.37	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	40.70	2.33	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	49.71	0.00	0.00	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	61.62	1.20	1.60	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	66.87	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	63.62	1.53	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	56.73	1.48	1.48	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	50.81	1.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	60.34	3.02	0.00	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	60.38	0.90	1.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	58.52	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	74.82	0.89	2.67	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	76.64	0.78	1.56	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	60.70	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	58.12	1.04	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	77.89	0.44	2.63	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	63.74	1.12	1.68	0.56	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	70.66	1.77	0.44	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	66.34	0.77	2.70	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	71.40	3.54	0.00	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	69.21	1.44	0.96	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.80	1.99	1.19	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	66.23	0.00	1.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	53.26	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	77.90	1.14	1.14	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	75.40	2.07	1.55	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	56.23	3.63	1.81	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	63.38	3.17	2.22	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	71.43	2.13	2.13	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	62.64	1.72	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	72.51	4.11	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	101.86	2.83	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.13	1.70	1.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	79.04	1.25	1.66	0.00	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	86.13	0.78	2.35	0.78	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	72.24	2.92	0.84	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	80.85	0.00	0.93	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	84.30	2.68	1.34	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	85.54	1.60	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	88.09	1.62	1.21	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	97.28	0.00	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	76.46	1.78	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	95.17	1.71	2.28	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	78.22	1.53	1.53	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	70.59	4.92	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	93.99	4.01	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	81.63	2.86	3.38	0.00	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	75.59	1.99	1.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	112.24	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	94.13	0.91	2.73	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	38.54	3.30	1.84	1.84	0.00
Macrophage - monocyte derived, donor3	11389-118C3	65.67	2.62	1.44	1.84	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	21.24	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	37.24	0.79	0.79	0.48	0.00
Mallassez-derived cells, donor3	11930-125I4	53.93	0.83	1.11	0.42	0.28
Mammary Epithelial Cell, donor1	11273-116H4	50.02	1.79	0.70	0.70	0.00
Mammary Epithelial Cell, donor2	11350-117G9	52.70	1.45	0.87	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	36.42	0.75	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	237.28	4.07	8.81	0.00	0.00
Mast cell, donor1	11563-120D6	230.45	2.60	5.62	2.16	0.65
Mast cell, donor2	11565-120D8	191.08	8.32	4.75	3.57	0.59
Mast cell, donor3	11566-120D9	267.00	4.95	4.05	0.00	3.15
Mast cell, donor4	11567-120E1	213.10	5.50	3.19	0.71	2.30
Mast cell, expanded and stimulated, donor5	11940-126A5	144.27	4.21	2.77	2.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	282.50	4.09	7.00	1.17	0.58
Mast cell, expanded, donor5	11939-126A4	105.43	2.75	1.95	2.41	0.00
Mast cell, expanded, donor8	11941-126A6	248.54	3.51	2.51	1.17	1.00
Melanocyte - dark, donor1	11502-119F8	38.90	1.09	0.70	0.80	0.30
Melanocyte - dark, donor2	11582-120F7	26.99	0.00	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	80.34	1.67	0.65	0.14	0.14
Melanocyte - light, donor1	11274-116H5	49.84	1.41	0.47	0.71	0.00
Melanocyte - light, donor2	11351-117H1	25.25	1.36	0.68	0.68	0.00
Melanocyte - light, donor3	11423-118G1	26.88	0.00	2.60	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.00	1.35	0.52	0.62	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	55.94	0.00	0.27	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	86.79	1.34	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	91.56	3.85	1.36	0.62	0.25
Meningeal Cells, donor2	11573-120E7	48.42	4.40	1.32	2.20	0.00
Meningeal Cells, donor3	11654-122E7	83.46	3.75	0.90	1.22	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	42.49	3.42	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	54.95	0.50	1.41	0.40	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	10.51	0.00	0.00	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	19.62	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	56.75	0.42	0.64	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.76	1.01	1.51	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.92	0.66	0.88	0.66	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	43.10	0.73	2.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	36.01	1.84	0.82	1.02	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	26.32	0.97	0.42	1.11	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.79	0.37	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	51.18	1.32	0.79	1.05	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	23.74	0.59	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	23.36	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	23.05	1.92	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	62.38	1.77	0.35	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	46.91	0.63	0.00	1.25	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	28.30	1.45	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	39.51	1.33	0.53	1.06	0.00
Mesothelial Cells, donor2	12156-128G5	38.54	1.50	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	35.41	1.16	1.37	0.43	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	120.18	10.80	13.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	67.23	2.96	2.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	55.06	2.06	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	55.31	10.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	53.62	1.86	0.31	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	40.45	2.07	0.83	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	4.63	4.63	2.32	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	73.08	1.75	1.00	0.25	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	82.39	3.72	3.72	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	66.45	2.85	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	49.50	1.19	0.79	0.00	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	45.13	0.00	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	36.85	1.52	0.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	32.90	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.98	1.70	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	41.44	1.84	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	54.25	0.89	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	53.65	1.68	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	39.14	1.00	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	44.21	2.38	0.71	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.77	1.11	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.78	1.38	0.92	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	31.97	1.47	0.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	27.92	0.41	2.04	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	33.25	1.29	0.21	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	35.57	2.00	2.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.84	0.44	0.66	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	34.98	3.04	2.53	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	0.00	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.63	0.82	2.99	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.11	2.06	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	26.43	0.48	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.81	0.40	0.80	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	42.51	2.74	5.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	16.02	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	34.65	2.04	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.52	0.44	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	41.94	1.10	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	42.91	1.28	1.28	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.77	0.74	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	0.70	2.78	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	28.03	0.68	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	35.45	2.19	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	52.55	3.55	2.49	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	26.37	1.68	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	33.25	1.66	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	52.45	3.50	2.33	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.17	1.21	0.90	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	43.83	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	51.22	1.71	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	44.91	2.07	0.97	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.65	1.30	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	57.91	2.57	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	34.94	1.27	3.18	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	45.37	0.53	1.33	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	47.59	1.80	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	44.92	1.84	0.85	0.71	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	34.08	0.64	0.64	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	43.12	2.43	1.33	0.44	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	44.75	2.28	2.28	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	41.76	0.85	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	38.10	2.95	0.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	63.86	5.21	1.96	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	54.40	1.18	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	53.34	2.31	1.15	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	63.06	2.89	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	43.48	0.30	0.60	0.60	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	32.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	65.06	0.99	0.33	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	34.71	1.05	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	53.38	1.78	0.79	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	59.60	1.86	1.86	0.93	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	57.08	1.88	1.13	2.25	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	33.29	2.66	0.80	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.28	0.34	0.90	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	58.26	2.20	1.10	0.73	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	1.56	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.26	1.07	0.53	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	48.48	2.02	1.01	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.51	0.84	0.84	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	0.00	6.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	0.00	1.91	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	5.67	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	3.02	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	102.78	0.00	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	3.26	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	65.06	2.15	1.29	0.00	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	53.31	2.09	1.05	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	132.16	4.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	179.47	3.76	2.09	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	278.56	13.12	1.52	3.42	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	248.95	4.79	0.00	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	68.67	3.40	0.00	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	90.04	1.84	1.84	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	70.73	2.93	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	156.90	2.09	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	117.01	4.59	0.27	0.81	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	93.13	2.73	0.84	1.26	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	56.09	2.98	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	100.15	3.25	0.27	1.62	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	94.07	1.59	0.45	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	127.54	3.27	0.16	2.29	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	73.45	2.19	0.55	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	56.23	2.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	66.03	2.40	0.60	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	182.47	11.81	3.28	2.63	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	120.02	1.14	0.65	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	114.82	4.23	2.12	1.23	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	59.07	1.41	0.00	4.22	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	88.72	2.30	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	68.77	0.64	0.00	1.93	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	215.21	1.72	2.41	0.34	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	118.84	12.64	17.70	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	112.28	3.34	1.11	1.11	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	88.49	1.69	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	129.83	4.98	0.24	1.19	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	61.81	3.43	0.43	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	171.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	67.31	2.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	123.99	4.06	3.16	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	57.14	1.19	0.40	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	73.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	57.13	1.89	0.00	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	79.52	0.65	0.65	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	71.47	3.92	0.87	2.61	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	123.93	2.71	1.36	4.07	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	61.73	1.76	0.88	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	73.80	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	53.57	1.49	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	94.94	2.30	2.30	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	48.09	1.51	0.30	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	86.86	1.55	2.21	1.33	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	65.05	2.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	86.86	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	46.95	1.22	0.61	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	112.36	0.94	1.57	0.00	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	110.77	3.33	0.91	1.82	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	59.34	0.79	0.00	3.16	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	149.64	14.74	3.40	5.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	5.06	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	42.49	1.86	0.75	0.25	0.00
Myoblast, donor2	11322-117D8	47.56	2.88	1.15	0.96	0.00
Myoblast, donor3	11398-118D3	45.40	1.35	1.68	0.84	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	124.77	4.23	4.82	2.04	0.15
Natural Killer Cells, donor1	11230-116C6	109.78	3.69	4.31	4.31	0.62
Natural Killer Cells, donor2	11311-117C6	124.24	5.43	2.11	0.60	0.30
Natural Killer Cells, donor3	11387-118C1	113.19	4.05	3.31	3.13	0.00
Neural stem cells, donor1	11275-116H6	91.10	5.08	4.72	1.45	0.00
Neural stem cells, donor2	11352-117H2	55.84	5.78	3.85	3.85	0.00
Neurons, donor1	11494-119E9	45.52	2.28	1.14	4.55	0.00
Neurons, donor2	11574-120E8	25.54	2.64	1.98	3.08	0.22
Neurons, donor3	11655-122E8	71.53	7.40	1.64	4.93	1.64
Neutrophils, donor1	11233-116C9	588.36	8.35	31.55	4.64	0.93
Neutrophils, donor2	11314-117C9	339.17	8.70	8.70	8.70	0.00
Neutrophils, donor3	11390-118C4	1066.53	26.27	39.09	12.22	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	40.73	2.02	1.66	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	32.23	0.65	0.65	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	35.30	1.20	0.00	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	60.15	2.48	0.55	1.10	0.28
Olfactory epithelial cells, donor2	11934-125I8	66.29	2.75	1.74	0.72	0.43
Olfactory epithelial cells, donor3	11935-125I9	50.51	2.50	1.14	1.14	0.00
Olfactory epithelial cells, donor4	11936-126A1	85.32	2.14	1.07	0.78	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	48.75	0.00	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	27.44	1.49	0.64	0.85	0.00
Osteoblast - differentiated, donor2	11353-117H3	18.29	2.29	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	29.17	0.62	1.24	0.62	0.00
Osteoblast, donor1	11277-116H8	28.14	1.37	0.78	0.39	0.00
Osteoblast, donor2	11354-117H4	48.46	3.51	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	55.63	3.55	1.24	0.53	0.18
Pancreatic stromal cells, donor1	11249-116E7	52.48	0.67	0.67	0.42	0.00
Pericytes, donor1	11491-119E6	34.16	1.67	0.45	0.11	0.45
Pericytes, donor2	11571-120E5	28.75	2.49	0.45	0.68	0.00
Pericytes, donor3	11652-122E5	46.79	1.22	1.22	0.41	0.00
Perineurial Cells, donor1	11499-119F5	38.09	1.47	0.00	1.02	0.00
Perineurial Cells, donor2	11579-120F4	38.74	1.56	0.83	0.09	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	176.58	5.42	4.78	3.82	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	142.02	1.71	4.41	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	102.76	6.86	3.62	3.62	0.39
Placental Epithelial Cells, donor1	11278-116H9	16.98	0.00	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	11.98	1.18	0.39	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	37.02	1.58	0.00	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	31.89	0.75	1.31	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	40.20	0.91	0.13	0.65	0.39
Preadipocyte - breast, donor2	11328-117E5	42.78	3.15	0.68	0.45	0.23
Preadipocyte - omental, donor1	11468-119C1	59.14	2.34	1.70	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	50.19	1.31	2.18	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	81.65	1.72	2.15	1.15	0.57
Preadipocyte - perirenal, donor1	11469-119C2	31.50	1.97	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	47.91	0.92	0.31	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	71.01	2.66	0.53	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	51.26	1.70	0.85	1.02	0.00
Preadipocyte - visceral, donor1	11280-116I2	83.09	1.68	0.75	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	84.21	1.84	1.38	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	56.63	1.15	0.73	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	81.76	1.66	1.96	0.60	0.60
Prostate Epithelial Cells, donor2	11331-117E8	38.59	1.90	0.68	0.54	0.14
Prostate Epithelial Cells, donor3	11404-118D9	73.73	2.57	3.61	0.98	0.18
Prostate Stromal Cells, donor1	11254-116F3	55.47	2.16	1.25	0.57	0.00
Prostate Stromal Cells, donor2	11332-117E9	64.55	1.79	0.36	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	61.42	1.77	1.25	0.42	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.91	0.73	2.55	1.09	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.35	2.08	0.62	0.55	0.55
Renal Epithelial Cells, donor1	11517-119H5	21.81	1.01	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	18.49	0.71	0.00	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	33.88	2.86	0.85	1.48	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	27.23	2.72	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	39.76	1.89	0.27	1.35	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	66.60	2.00	1.55	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	19.96	1.33	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	27.51	1.76	1.76	0.88	0.00
Renal Mesangial Cells, donor2	11598-120H5	30.72	0.63	0.00	1.25	0.63
Renal Mesangial Cells, donor3	11679-122H5	11.37	0.55	0.55	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	57.71	1.07	0.00	1.07	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.52	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	31.24	1.35	0.39	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.85	1.30	0.26	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.27	1.42	0.85	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	21.61	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	35.13	0.75	0.50	1.51	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	107.98	4.01	2.54	1.60	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	123.29	6.25	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	160.16	6.60	1.65	1.65	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	193.16	9.28	3.48	4.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	108.96	2.99	1.43	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	93.94	3.38	0.60	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	95.59	2.68	1.12	1.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	77.15	3.97	1.12	0.50	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	96.15	2.21	0.47	0.93	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	105.63	2.54	1.16	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	92.96	2.88	1.10	1.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	93.18	2.87	1.06	1.51	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	99.99	1.61	0.90	1.79	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	72.73	4.02	1.00	2.01	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	84.89	2.36	1.18	0.86	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	101.78	3.10	0.22	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	95.21	4.01	1.34	0.96	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	107.51	3.73	1.21	1.58	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	103.72	2.82	2.44	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	102.45	5.18	1.99	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	104.74	3.50	1.56	1.46	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	93.95	2.67	1.15	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	85.76	3.52	0.75	1.50	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	92.78	2.24	2.52	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	108.01	3.25	1.88	1.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	102.29	6.20	0.91	1.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	94.06	2.70	0.74	1.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	95.10	3.09	0.94	1.34	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	65.10	3.07	1.18	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	100.99	4.37	1.39	1.19	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	105.23	3.98	0.94	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	82.11	2.90	0.41	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	88.48	1.55	1.11	2.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	109.04	3.97	2.09	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	88.42	4.85	1.75	1.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	132.49	6.81	1.02	2.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	123.39	5.01	3.08	2.51	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	72.04	3.61	0.86	1.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	119.06	4.39	1.23	1.78	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	109.83	4.43	1.64	1.31	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	85.04	4.43	0.85	2.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	87.29	3.11	1.48	1.18	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	97.02	3.73	2.13	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	81.72	6.36	1.24	0.97	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	82.38	4.52	0.95	1.19	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	141.48	5.04	2.22	2.22	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	65.26	3.11	1.04	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	117.39	3.84	2.45	2.79	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	117.86	5.44	1.21	3.32	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	77.59	4.28	0.73	1.10	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	151.81	6.11	3.35	1.16	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	80.92	3.04	0.61	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	83.49	2.71	0.60	1.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	120.11	6.33	1.36	2.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	112.93	3.89	0.60	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	88.91	4.37	0.83	1.89	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	121.45	5.34	1.49	0.85	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	100.96	6.01	2.40	0.00	0.00
Schwann Cells, donor1	11498-119F4	32.91	1.88	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	51.04	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	32.64	1.75	0.00	0.88	0.00
Sebocyte, donor1	11220-116B5	51.49	0.55	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	40.90	0.92	0.00	0.92	0.46
Sebocyte, donor3	11378-118B1	42.25	1.65	0.41	0.62	0.00
Sertoli Cells, donor1	11255-116F4	69.58	0.00	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	50.84	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	36.25	1.85	1.41	0.44	0.18
Skeletal Muscle Cells, donor2	11358-117H8	18.79	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	36.79	0.00	0.00	0.84	0.84
Skeletal Muscle Cells, donor4	11451-119A2	46.03	2.36	0.63	0.79	0.00
Skeletal Muscle Cells, donor5	11455-119A6	45.34	1.93	0.15	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	70.64	2.00	0.46	0.77	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	41.08	2.39	0.50	1.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	41.95	1.28	0.43	0.86	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	63.10	3.08	0.50	1.09	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	36.57	1.52	1.01	0.93	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.78	0.72	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.63	0.55	0.69	0.14	0.14
Skin - palm, donor1	10286-104F7	201.46	2.69	2.69	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	53.19	2.59	0.58	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	95.69	0.00	1.64	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	61.28	1.43	1.17	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	55.33	1.25	1.95	0.14	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	89.74	3.66	1.97	0.42	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	101.28	1.90	0.85	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	142.86	2.40	5.02	0.07	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.10	1.23	1.85	1.54	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	28.90	0.89	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	42.91	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	56.57	2.87	1.99	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	36.62	0.39	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	27.04	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	25.02	1.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	54.96	3.46	1.33	1.06	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	43.67	1.33	0.22	0.22	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	72.85	1.79	1.02	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	51.12	1.63	0.00	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	59.66	0.59	1.48	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	49.83	1.85	0.57	1.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	36.11	0.65	0.33	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	75.80	2.13	0.91	1.22	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	37.38	2.02	0.76	1.01	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	55.09	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.33	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	47.49	0.29	0.44	0.00	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	38.10	1.08	0.86	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.50	1.15	0.31	0.94	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	51.97	1.08	1.08	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	43.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	46.62	1.49	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	23.56	1.37	0.68	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	29.37	1.18	0.16	0.39	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	77.29	2.31	1.51	0.91	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	63.03	0.46	1.37	0.00	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.98	1.81	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	58.55	2.65	0.79	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	72.17	2.00	0.67	0.53	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	61.98	0.63	1.25	0.50	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.13	0.00	0.76	0.51	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	55.94	1.36	1.21	1.21	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	35.26	1.50	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	255.86	5.17	2.58	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.55	1.86	1.40	0.93	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	52.00	1.51	0.50	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	75.84	1.88	1.88	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.12	0.59	0.00	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	64.31	2.08	1.08	1.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	38.77	0.47	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	54.98	1.30	1.01	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	42.83	1.27	1.02	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	39.68	2.07	0.75	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	39.97	1.96	0.70	0.28	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	40.72	0.34	0.59	0.50	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.29	0.95	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	47.95	0.98	0.49	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	145.60	1.55	1.10	0.44	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	26.92	0.59	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	55.20	0.78	0.78	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	48.39	2.38	0.26	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	53.19	1.12	0.74	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	44.56	1.08	0.36	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	46.28	0.28	1.14	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	59.87	1.58	1.58	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	48.00	1.02	1.27	0.51	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	76.67	3.19	1.20	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	49.32	0.42	1.25	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	43.09	0.46	0.46	0.92	0.00
Synoviocyte, donor1	11291-117A4	52.18	1.01	1.85	0.67	0.00
Synoviocyte, donor2	11368-117I9	31.51	0.84	1.01	0.34	0.34
Synoviocyte, donor3	11440-118H9	30.38	2.23	0.45	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	52.17	1.07	0.71	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	28.48	0.93	0.69	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	50.39	2.01	1.15	0.50	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	18.94	1.16	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	26.34	2.29	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	107.89	2.58	2.21	0.86	0.25
Urethra, donor2	10319-105A4	149.27	7.19	1.80	0.00	1.80
Urothelial Cells, donor1	11520-119H8	40.65	0.80	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	26.84	1.20	0.80	1.60	0.00
Urothelial Cells, donor3	11681-122H7	29.11	0.46	0.46	0.46	0.00
Urothelial cells, donor0	11216-116B1	70.66	0.67	1.34	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	1262.60	26.69	87.20	16.91	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	1278.07	32.88	98.64	5.72	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	818.00	26.70	65.71	6.85	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	577.45	12.05	28.92	4.82	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	411.95	8.13	30.79	5.23	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	995.43	18.74	90.59	4.16	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	1122.46	26.62	92.70	9.18	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	874.56	25.56	61.16	4.56	0.91
Wilms' tumor cell line:G-401	10809-111A8	50.70	1.36	0.99	0.62	0.00
Wilms' tumor cell line:HFWT	10597-108E3	84.48	7.04	3.52	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	86.31	3.35	1.96	0.84	0.00
achilles tendon, donor2	10292-104G4	140.52	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	75.21	4.59	2.55	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	94.26	1.86	1.39	0.93	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	81.43	8.31	4.51	2.85	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	94.97	5.71	3.54	1.63	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	92.20	2.53	2.25	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	59.21	4.65	1.48	1.06	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	82.21	6.26	7.62	2.45	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	86.37	1.76	0.44	1.32	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	87.80	4.49	0.41	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	161.53	2.72	1.94	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	81.33	1.84	1.84	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	0.00	7.80	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	86.91	1.86	1.63	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	73.53	3.11	0.26	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	72.18	2.63	2.34	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	84.12	4.18	3.72	2.32	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	86.77	0.82	5.76	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	139.05	5.22	1.84	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	111.80	2.13	1.71	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.98	3.34	1.21	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	87.86	2.41	2.41	0.48	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	165.72	2.45	5.35	0.89	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	139.76	5.00	3.67	2.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	382.79	7.43	24.16	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	132.58	3.39	4.90	2.26	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	146.98	6.11	7.41	4.36	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	326.16	3.75	24.37	7.50	0.00
adenocarcinoma cell line:IM95m	10796-110I4	106.45	1.88	0.71	1.41	0.24
adipose tissue, adult, pool1	10010-101C1	121.77	1.71	3.88	0.31	0.62
adipose, donor1	10184-103D4	73.89	5.86	1.17	2.35	0.00
adipose, donor2	10185-103D5	96.51	6.08	0.81	1.22	1.22
adipose, donor3	10186-103D6	83.05	6.81	0.54	1.36	0.54
adipose, donor4	10187-103D7	124.81	6.93	1.73	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	75.44	10.57	6.94	2.53	3.47
adrenal gland, adult, pool1	10081-102A9	80.03	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	85.38	4.54	1.87	2.93	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	121.48	1.79	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	49.62	1.16	0.70	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	45.31	1.69	0.68	0.34	1.01
amniotic membrane cells, donor3	12237-129G5	38.59	1.77	0.88	0.29	0.59
amygdala - adult, donor10196	10167-103B5	543.10	17.79	20.16	8.30	1.19
amygdala, adult, donor10252	10151-102I7	420.13	24.33	17.64	8.11	4.87
amygdala, newborn, donor10223	10360-105E9	174.62	33.89	12.59	14.20	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	30.18	0.89	2.80	1.15	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	99.50	2.43	1.32	0.88	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	82.17	4.01	2.67	2.34	0.33
aorta, adult, pool1	10052-101G7	81.98	2.35	1.57	2.35	0.20
appendix, adult	10189-103D9	122.65	8.93	5.05	3.49	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	47.46	1.03	2.75	0.34	0.00
artery, adult	10190-103E1	107.34	2.72	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	65.05	2.17	2.46	0.29	1.01
b cell line:RPMI1788	10427-106D4	40.74	1.78	1.93	0.59	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	53.27	0.55	1.11	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	52.49	2.88	4.56	0.30	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	73.65	1.17	0.84	0.67	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	88.92	2.80	2.24	0.56	0.00
bladder, adult, pool1	10011-101C2	111.36	1.20	3.26	1.85	0.87
blood, adult, pool1	10053-101G8	710.90	24.36	44.29	2.21	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	100.19	0.86	5.14	2.57	0.86
bone marrow, adult	10192-103E3	76.93	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	363.90	16.40	5.13	3.08	2.05
brain, adult, pool1	10012-101C3	410.47	29.40	12.69	11.14	2.23
brain, fetal, pool1	10085-102B4	130.90	13.36	5.34	5.34	2.67
breast carcinoma cell line:MCF7	10482-107A5	130.82	6.28	5.62	0.33	3.96
breast carcinoma cell line:MDA-MB-453	10419-106C5	68.53	2.37	3.62	0.12	1.50
breast, adult, donor1	10080-102A8	189.41	6.94	3.79	2.53	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	60.34	1.02	0.38	0.13	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	106.68	2.16	1.55	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	46.04	5.30	2.53	0.92	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	55.44	4.12	0.97	1.45	0.24
carcinoid cell line:NCI-H1770	10703-109H1	94.03	3.29	0.94	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	100.85	6.34	4.38	3.61	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	80.49	4.44	0.32	3.17	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	102.48	4.26	2.40	3.19	0.53
caudate nucleus - adult, donor10196	10177-103C6	694.25	43.75	27.63	9.21	1.15
caudate nucleus, adult, donor10252	10164-103B2	558.37	37.82	23.93	8.03	4.02
caudate nucleus, adult, donor10258	10379-105H1	447.79	71.83	36.68	16.81	4.58
caudate nucleus, newborn, donor10223	10354-105E3	186.41	42.85	19.04	15.38	1.10
cerebellum - adult, donor10196	10173-103C2	506.91	29.13	5.83	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	542.10	16.01	5.98	6.19	5.34
cerebellum, adult, pool1	10083-102B2	263.54	13.11	1.72	2.76	2.07
cerebellum, newborn, donor10223	10357-105E6	190.14	9.96	4.98	9.96	0.83
cerebral meninges, adult	10188-103D8	524.20	26.73	13.87	2.52	6.30
cerebrospinal fluid, donor2	10294-104G6	157.14	2.19	3.65	0.00	1.46
cervical cancer cell line:D98-AH2	10552-107I3	71.17	2.59	1.73	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	46.23	2.49	6.13	2.49	0.17
cervix, adult, pool1	10013-101C4	122.10	3.25	3.46	2.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	50.30	1.81	1.81	1.11	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	105.81	5.23	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	67.48	2.73	1.62	0.87	0.25
choriocarcinoma cell line:SCH	10785-110H2	55.82	2.59	1.72	1.72	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	114.32	4.98	2.13	2.61	1.42
chorionic membrane cells, donor1	12238-129G6	49.86	0.85	2.28	0.57	0.28
chorionic membrane cells, donor2	12239-129G7	65.53	2.29	1.09	0.50	0.20
chorionic membrane cells, donor3	12240-129G8	58.25	2.75	1.10	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	24.24	1.01	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	95.67	2.11	0.96	0.19	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	222.38	2.11	4.65	0.63	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	67.28	1.80	0.00	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	85.62	1.94	0.24	1.21	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	77.17	2.24	0.20	0.61	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	110.13	1.18	0.29	1.18	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	166.80	5.73	7.04	1.04	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	22.86	3.43	1.14	1.83	0.00
clear cell carcinoma cell line:TEN	10636-108I6	64.89	1.56	0.87	0.52	0.52
colon carcinoma cell line:CACO-2	10513-107D9	77.43	1.83	1.46	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	258.84	3.04	3.80	0.38	0.00
colon, adult, donor1	10082-102B1	107.10	7.14	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	103.05	2.94	0.82	1.41	0.24
colon, fetal, donor1	10070-101I7	121.13	4.94	1.24	6.18	0.00
common myeloid progenitor CMP, donor1	12130-128D6	586.69	13.75	9.17	0.00	13.75
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	94.76	1.70	1.27	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	98.71	2.72	1.21	0.30	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	84.75	2.68	0.71	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	111.56	4.20	3.54	2.21	1.00
cruciate ligament, donor2	10295-104G7	109.41	1.62	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	130.82	2.41	4.01	3.21	0.00
diencephalon, adult	10193-103E4	289.43	24.24	18.24	5.04	2.40
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	61.77	2.76	0.00	1.61	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	105.14	4.62	4.87	2.56	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	49.35	3.85	0.48	0.00	0.24
ductus deferens, adult	10196-103E7	76.25	3.99	1.00	2.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	95.06	5.76	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	66.94	2.94	3.68	2.94	0.00
dura mater, adult, donor1	10041-101F5	156.67	3.39	3.39	0.83	1.65
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	75.06	2.44	6.00	0.22	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	57.89	1.72	2.58	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	245.41	11.10	4.32	7.40	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	107.16	4.54	1.82	1.82	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	193.89	8.34	4.32	3.70	1.54
embryonic pancreas cell line:2C6	10603-108E9	154.99	10.51	11.82	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	91.51	1.34	1.01	1.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	78.84	2.90	4.53	0.36	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	46.15	2.73	1.45	0.16	0.16
epidermoid carcinoma cell line:A431	10426-106D3	81.70	3.11	2.56	1.22	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	89.09	3.19	2.42	0.77	0.22
epididymis, adult	10197-103E8	77.45	2.93	2.93	3.35	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	56.59	2.48	0.53	0.18	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	60.95	1.97	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	64.08	2.36	2.88	0.92	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	70.76	3.44	4.53	1.28	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	69.46	2.02	2.46	1.68	0.00
esophagus, adult, pool1	10015-101C6	85.37	3.29	2.87	0.74	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	78.27	6.14	1.88	3.63	0.13
eye - muscle inferior rectus, donor1	10272-104E2	125.56	7.24	12.07	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	79.96	0.00	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	151.80	5.95	2.98	2.98	0.00
eye - muscle superior, donor2	10297-104G9	134.14	3.44	4.59	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	90.36	4.37	2.91	4.37	1.46
eye, fetal, donor1	10054-101G9	77.03	3.31	3.05	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	51.29	2.69	1.54	1.15	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	84.52	3.80	2.14	2.14	0.24
frontal lobe, adult, pool1	10040-101F4	458.80	22.33	15.11	5.63	6.10
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	93.98	3.00	2.10	1.20	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	95.46	2.10	0.73	0.73	0.27
gall bladder, adult	10198-103E9	85.71	3.86	1.93	0.72	0.48
gamma delta positive T cells, donor1	11937-126A2	97.17	1.07	2.68	2.15	0.54
gamma delta positive T cells, donor2	11938-126A3	121.38	4.86	2.99	2.24	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.11	2.32	1.90	1.06	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	80.65	2.32	1.93	1.93	0.19
gastric cancer cell line:AZ521	10549-107H9	60.83	4.26	1.15	1.15	0.00
gastric cancer cell line:GSS	10560-108A2	54.00	0.92	6.41	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	74.71	2.97	4.57	0.46	0.91
giant cell carcinoma cell line:LU65	10487-107B1	28.91	1.03	1.03	1.03	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	101.61	4.62	2.38	0.84	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	69.09	2.24	3.74	3.24	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	55.84	1.90	0.84	1.48	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	80.75	1.12	1.69	1.40	0.00
glioblastoma cell line:T98G	10485-107A8	69.65	0.99	1.10	0.22	0.00
glioma cell line:GI-1	10413-106B8	56.82	0.88	1.17	1.46	0.29
globus pallidus - adult, donor10196	10175-103C4	455.57	21.87	15.31	6.56	2.92
globus pallidus, adult, donor10252	10161-103A8	171.84	10.25	11.96	0.98	1.46
globus pallidus, adult, donor10258	10367-105F7	83.52	2.74	6.85	4.11	0.00
globus pallidus, newborn, donor10223	10364-105F4	139.09	19.19	7.99	10.66	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	467.40	9.79	34.26	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	99.84	1.92	0.96	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	67.49	3.21	2.75	3.67	0.92
hIPS +CCl2, biol_rep2	14384-156C1	70.88	4.12	2.29	3.20	0.00
hIPS +CCl2, biol_rep3	14385-156C2	74.71	0.64	1.29	0.64	0.00
hIPS, biol_rep1	14380-156B6	67.55	0.00	2.87	1.44	0.00
hIPS, biol_rep2	14381-156B7	89.16	4.12	2.74	2.06	0.00
hIPS, biol_rep3	14382-156B8	193.11	12.14	13.24	18.76	0.00
hairy cell leukemia cell line:Mo	10712-109I1	44.54	2.87	1.44	0.86	0.29
heart - mitral valve, adult	10205-103F7	92.98	2.69	1.79	0.00	2.09
heart - pulmonic valve, adult	10206-103F8	64.58	3.40	3.14	1.83	0.00
heart - tricuspid valve, adult	10207-103F9	97.42	5.00	9.16	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	54.07	2.65	2.04	1.43	0.82
heart, adult, diseased, donor1	10051-101G6	37.05	3.83	0.00	0.85	0.00
heart, adult, pool1	10016-101C7	77.73	2.76	2.76	1.15	0.46
heart, fetal, pool1	10046-101G1	81.22	3.59	5.24	2.36	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	123.10	2.16	2.47	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	165.30	10.70	4.76	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	137.35	2.21	2.32	1.55	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	128.54	3.52	1.58	1.34	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	136.52	3.94	2.02	1.72	0.00
hepatoma cell line:Li-7	10484-107A7	62.06	1.00	0.44	0.78	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	58.39	3.52	1.51	1.11	0.00
hippocampus - adult, donor10196	10169-103B7	735.30	35.96	30.28	17.03	1.89
hippocampus, adult, donor10252	10153-102I9	362.69	22.66	14.29	5.71	3.27
hippocampus, adult, donor10258	10374-105G5	269.89	20.91	10.95	17.93	0.00
hippocampus, newborn, donor10223	10363-105F3	331.33	49.70	13.04	20.80	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	52.49	6.10	0.61	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	65.58	5.11	1.37	2.55	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	55.10	6.60	0.00	2.29	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	74.99	3.95	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	86.50	3.36	0.26	0.52	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	53.52	3.80	0.00	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	45.54	1.46	1.17	3.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	61.83	6.03	0.43	2.15	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	52.55	1.25	0.42	4.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	31.73	2.13	0.71	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	58.98	3.38	0.32	1.29	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	32.99	2.69	2.02	2.02	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	74.17	4.38	0.63	1.41	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	84.50	5.40	1.47	1.97	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.97	7.85	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	125.81	3.44	0.38	1.15	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	105.09	2.18	0.00	1.31	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	88.46	4.50	0.50	2.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	67.63	3.58	0.19	2.07	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	71.85	3.64	0.45	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.82	4.07	0.31	2.82	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	71.04	4.25	0.82	0.49	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	67.06	1.16	0.58	0.29	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	71.14	4.78	0.60	1.79	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	105.86	4.62	0.92	0.92	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	104.13	5.14	0.86	0.57	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	89.01	6.53	1.63	0.82	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	99.64	3.87	0.35	1.06	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	93.44	2.85	0.95	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	88.37	2.42	0.61	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	61.02	1.55	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	73.72	1.33	0.00	0.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.53	0.26	0.00	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	51.13	1.28	0.51	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.91	1.51	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	76.96	4.37	4.03	0.67	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	102.16	4.59	0.97	1.21	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	84.68	1.78	0.89	1.78	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	113.17	4.39	0.98	0.49	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	91.69	4.58	0.31	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	74.82	0.00	3.25	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	73.47	3.97	0.33	0.66	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	71.70	1.64	1.64	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	48.85	2.90	1.09	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	43.77	3.20	1.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	68.02	1.19	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	75.30	3.39	1.22	0.27	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	73.28	2.96	1.35	0.54	0.27
immature langerhans cells, donor1	11904-125F5	109.69	2.18	6.05	0.48	0.48
immature langerhans cells, donor2	11905-125F6	89.51	1.58	3.17	1.58	0.00
insula, adult, pool1	10039-101F3	477.52	31.61	19.68	10.41	4.26
keratoacanthoma cell line:HKA-1	10791-110H8	34.14	2.60	0.98	0.33	0.00
kidney, adult, pool1	10017-101C8	65.08	2.80	1.40	1.30	0.50
kidney, fetal, pool1	10045-101F9	55.88	2.69	3.47	0.99	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	100.27	1.85	2.41	0.14	1.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	40.37	1.52	0.69	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	119.83	2.39	7.89	0.37	1.28
left atrium, adult, donor1	10079-102A7	82.27	2.18	1.09	1.63	0.00
left ventricle, adult, donor1	10078-102A6	103.15	2.53	2.02	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	196.73	4.92	4.38	2.74	0.00
leiomyoma cell line:10964C	10569-108B2	33.05	0.72	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	29.35	0.54	0.54	0.00	0.54
leiomyoma cell line:15425	10571-108B4	38.36	0.24	0.73	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	73.19	0.00	4.18	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	100.00	3.78	3.90	1.42	0.00
liposarcoma cell line:KMLS-1	10782-110G8	86.70	0.78	1.41	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	58.36	1.34	0.49	0.97	0.00
liver, adult, pool1	10018-101C9	90.43	2.59	1.13	0.49	0.32
liver, fetal, pool1	10086-102B5	86.55	5.64	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	313.09	19.54	5.10	4.81	2.48
locus coeruleus, adult, donor10252	10165-103B3	159.82	5.17	4.06	1.85	1.85
locus coeruleus, adult, donor10258	10375-105G6	139.94	7.62	2.26	3.10	0.28
locus coeruleus, newborn, donor10223	10362-105F2	184.65	13.88	4.21	6.31	1.68
lung adenocarcinoma cell line:A549	10499-107C4	95.77	3.74	1.52	1.11	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	93.07	2.07	10.34	1.38	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	117.58	3.56	2.11	0.13	0.53
lung, adult, pool1	10019-101D1	118.95	4.02	4.25	2.13	0.71
lung, fetal, donor1	10068-101I5	199.21	8.85	10.56	4.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	184.20	6.42	3.21	4.58	0.46
lymph node, adult, donor1	10077-102A5	132.07	6.63	0.95	3.31	0.00
lymphangiectasia cell line:DS-1	10727-110A7	65.53	3.07	1.97	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	42.11	1.36	0.91	0.15	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	114.68	4.25	5.95	0.85	0.85
mature adipocyte, donor1	12231-129F8	210.90	3.11	6.66	0.00	0.44
mature adipocyte, donor2	12232-129F9	145.06	2.08	7.68	0.21	0.42
mature adipocyte, donor3	12233-129G1	140.34	1.66	4.50	1.42	0.00
mature adipocyte, donor4	12234-129G2	246.11	4.47	6.32	0.26	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	217.53	13.82	8.58	2.62	7.86
medial frontal gyrus - adult, donor10196	10170-103B8	653.13	36.10	13.54	1.13	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	603.58	28.51	12.32	9.75	4.23
medial frontal gyrus, adult, donor10258	10368-105F8	419.67	34.63	15.25	17.47	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	124.11	32.41	12.37	9.38	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	775.75	59.57	20.93	12.66	7.43
medial temporal gyrus, adult, donor10252	10156-103A3	602.29	29.29	14.86	8.70	4.88
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	308.20	19.26	13.48	36.60	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	531.08	43.06	57.41	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	217.15	40.92	12.20	15.08	2.51
medulla oblongata - adult, donor10196	10174-103C3	160.95	4.54	1.95	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	156.35	5.26	2.63	1.24	0.93
medulla oblongata, adult, pool1	10038-101F2	141.38	5.55	4.00	2.37	1.88
medulla oblongata, newborn, donor10223	10361-105F1	92.00	6.25	1.74	3.47	0.00
medulloblastoma cell line:D283 Med	10838-111E1	67.09	2.66	2.44	1.99	0.89
medulloblastoma cell line:ONS-76	10759-110E3	82.05	3.30	1.47	1.83	0.24
melanoma cell line:COLO 679	10514-107E1	97.32	1.44	2.16	0.00	1.29
melanoma cell line:G-361	10465-106H6	64.88	2.99	1.09	1.63	0.27
meningioma cell line:HKBMM	10691-109F7	33.65	0.36	0.54	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	148.92	8.81	2.64	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	55.99	5.96	0.52	3.63	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.52	1.07	0.00	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	42.72	0.91	0.55	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.19	0.83	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.02	0.84	0.28	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	23.88	1.93	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.76	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	38.27	0.69	0.51	0.34	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	29.79	1.04	0.46	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	36.34	0.93	0.13	0.13	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	42.81	1.08	0.41	0.14	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	63.16	1.85	0.85	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	63.24	2.31	1.32	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	59.92	0.97	1.11	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	45.38	0.00	1.05	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.44	0.61	0.82	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	42.78	1.80	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	31.86	0.72	0.31	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	32.60	0.46	0.68	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	40.28	2.10	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	39.90	1.49	0.90	0.15	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	45.25	1.31	0.35	0.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	68.48	0.00	1.47	1.10	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	42.07	0.86	1.14	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.84	3.37	1.26	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	23.29	1.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	29.16	1.79	0.77	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.79	1.05	0.26	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	36.05	0.62	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.60	1.65	0.24	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	27.41	1.69	0.00	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.90	0.79	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	23.17	0.93	0.46	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	33.46	1.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	27.66	1.12	0.67	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	31.01	0.96	0.72	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	54.27	3.67	1.47	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.22	0.34	0.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.38	0.82	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.63	1.29	0.00	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.96	0.32	0.32	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	26.65	1.07	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	37.32	0.00	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	32.02	1.19	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	2.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	14.57	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	34.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	25.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	34.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.08	0.41	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	22.40	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.99	0.62	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	30.29	0.69	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	43.05	0.00	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	29.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.89	0.00	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	43.93	0.81	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	34.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	50.37	1.21	0.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	9.04	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	42.01	2.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.95	0.60	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	33.75	0.32	0.32	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	2.04	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	48.74	3.87	4.64	2.32	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	89.06	4.49	1.65	4.96	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	68.34	1.85	2.09	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	95.76	2.98	1.44	1.23	0.10
mesothelioma cell line:Mero-25	10850-111F4	32.68	2.04	1.36	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	64.79	1.22	1.71	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	26.79	0.89	1.55	1.11	0.22
mesothelioma cell line:Mero-82	10853-111F7	65.44	2.10	0.53	1.58	0.00
mesothelioma cell line:Mero-83	10854-111F8	57.53	1.02	1.70	1.02	0.17
mesothelioma cell line:Mero-84	10855-111F9	30.33	0.51	1.26	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	35.20	0.41	0.62	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	95.58	1.66	1.49	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	46.51	0.90	0.54	0.18	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	44.41	1.02	1.02	0.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	36.39	2.54	1.02	1.27	0.25
mesothelioma cell line:No36	10857-111G2	52.84	1.96	0.98	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	52.29	0.27	0.54	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	71.40	1.15	2.88	1.54	0.38
migratory langerhans cells, donor2	11902-125F3	45.79	0.49	2.81	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	50.79	2.15	1.44	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	57.13	1.63	0.65	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	44.72	1.70	1.06	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	103.43	6.91	2.30	1.38	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	43.39	2.47	0.38	1.71	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	88.15	2.77	2.22	2.40	0.00
myeloma cell line:PCM6	10474-106I6	56.34	2.57	2.97	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	116.17	7.61	4.57	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	56.29	1.37	0.98	0.59	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	31.87	2.23	1.11	0.67	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	36.33	1.69	0.81	0.66	0.00
nasal epithelial cells, donor2	12227-129F4	54.65	2.76	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	158.28	4.14	2.53	3.68	1.84
neuroblastoma cell line:NB-1	10539-107G8	98.22	5.80	2.99	2.43	1.68
neuroblastoma cell line:NBsusSR	10607-108F4	24.04	3.59	0.63	1.27	0.00
neuroblastoma cell line:NH-12	10555-107I6	108.64	5.78	1.86	1.30	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	23.25	7.83	1.66	3.56	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	64.62	7.44	2.85	3.01	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	58.97	1.81	0.00	1.01	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	90.91	17.17	2.54	10.17	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	89.96	1.33	2.13	0.27	0.00
neutrophil PMN, donor1	12133-128D9	148.75	14.87	59.50	0.00	14.87
neutrophil PMN, donor2	12137-128E4	39.84	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	199.39	3.38	0.68	1.01	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	35.22	2.40	1.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	44.24	1.28	0.96	2.89	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.68	0.79	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	464.10	33.75	27.75	9.84	4.41
occipital cortex - adult, donor10196	10172-103C1	585.15	28.85	18.54	12.36	0.00
occipital cortex, adult, donor10252	10163-103B1	524.65	25.76	12.08	8.59	6.98
occipital cortex, newborn, donor10223	10355-105E4	231.47	46.22	17.83	23.29	1.46
occipital lobe, adult, donor1	10076-102A4	709.26	38.57	8.66	4.99	9.18
occipital lobe, fetal, donor1	10073-102A1	175.93	24.03	8.15	10.30	7.29
occipital pole, adult, pool1	10036-101E9	309.53	18.21	12.14	5.20	4.57
olfactory region, adult	10195-103E6	412.67	34.39	12.99	8.98	4.01
optic nerve, donor1	10277-104E7	96.05	0.00	6.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	69.26	1.48	1.94	0.80	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	100.98	1.65	1.10	0.14	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	48.60	1.52	2.54	0.00	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	65.26	2.54	0.69	0.58	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	45.27	2.35	1.76	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	135.48	10.28	1.87	13.08	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	60.86	1.27	0.64	1.27	0.21
ovary, adult, pool1	10020-101D2	76.61	2.80	4.11	1.66	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	83.04	2.75	2.02	0.92	0.37
pancreas, adult, donor1	10049-101G4	79.01	2.82	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	102.03	4.75	3.07	2.80	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	32.03	1.19	0.85	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	109.28	3.48	1.66	1.32	0.50
paracentral gyrus, adult, pool1	10035-101E8	404.80	28.65	15.10	8.69	4.03
parietal cortex, adult, donor10258	10373-105G4	287.73	36.70	24.22	13.95	0.00
parietal lobe - adult, donor10196	10171-103B9	537.96	30.10	9.40	8.46	2.82
parietal lobe, adult, donor10252	10157-103A4	580.62	29.07	11.97	7.98	4.56
parietal lobe, adult, pool1	10034-101E7	379.71	28.29	10.84	8.90	2.20
parietal lobe, fetal, donor1	10072-101I9	89.22	19.40	5.82	20.37	0.97
parietal lobe, newborn, donor10223	10356-105E5	177.21	37.39	13.46	21.31	1.87
parotid gland, adult	10199-103F1	95.58	4.93	3.70	1.23	0.62
penis, adult	10200-103F2	85.94	1.61	0.54	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	32.35	2.05	1.67	2.42	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	58.57	2.33	2.04	0.29	1.31
pineal gland - adult, donor10196	10179-103C8	211.57	5.16	3.87	5.16	0.65
pineal gland, adult, donor10252	10160-103A7	216.16	4.74	7.70	2.96	1.18
pineal gland, adult, donor10258	10377-105G8	89.04	6.27	3.14	1.88	1.25
pituitary gland - adult, donor10196	10180-103C9	122.43	1.01	1.01	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	173.55	5.73	7.82	2.61	2.61
pituitary gland, adult, donor10258	10378-105G9	61.29	6.81	2.55	6.81	0.00
placenta, adult, pool1	10021-101D3	61.92	3.55	3.33	1.61	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	65.55	1.72	1.72	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	59.14	0.93	0.93	0.47	0.93
pons, adult, pool1	10033-101E6	257.60	12.48	2.58	2.07	1.72
postcentral gyrus, adult, pool1	10032-101E5	346.17	24.32	9.33	6.36	1.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	294.89	16.73	25.10	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	73.12	1.89	1.02	0.29	0.44
prostate cancer cell line:PC-3	10439-106E7	114.53	3.27	3.27	1.45	0.00
prostate, adult, pool1	10022-101D4	79.54	2.54	3.36	1.45	0.54
putamen, adult, donor10196	10176-103C5	616.60	53.35	35.17	8.26	5.90
putamen, adult, donor10252	10152-102I8	358.81	27.45	13.73	13.73	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	262.27	15.30	49.18	22.95	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	420.16	69.10	56.05	19.09	0.97
putamen, newborn, donor10223	10365-105F5	244.39	49.48	12.74	17.24	1.50
rectal cancer cell line:TT1TKB	10469-106I1	134.70	1.75	2.33	0.00	0.29
rectum, fetal, donor1	10067-101I4	165.53	6.95	2.78	6.95	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	28.62	0.64	1.06	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.35	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	89.76	3.08	5.07	1.29	0.70
retinoblastoma cell line:Y79	10475-106I7	155.62	4.68	0.78	1.04	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	92.21	3.07	1.11	0.74	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	296.39	7.59	3.09	0.56	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	181.89	0.00	9.09	0.00	1.52
salivary acinar cells, donor1	11771-123I7	48.07	1.94	0.49	0.32	0.00
salivary acinar cells, donor2	11772-123I8	47.23	0.83	1.79	0.14	0.28
salivary acinar cells, donor3	11773-123I9	125.79	3.31	9.27	3.31	0.66
salivary gland, adult, pool1	10093-102C3	53.19	2.86	2.86	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	65.34	1.69	0.59	0.25	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	82.99	1.88	0.35	0.24	0.35
seminal vesicle, adult	10201-103F3	131.74	1.59	4.23	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	74.58	1.94	2.67	0.00	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	42.27	1.01	0.75	0.50	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	59.21	2.01	2.01	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	38.15	2.55	0.54	0.40	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	61.78	2.43	1.22	1.33	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	86.06	0.90	2.45	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	107.82	2.84	5.67	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	99.19	3.12	5.52	1.92	0.72
skeletal muscle, fetal, donor1	10066-101I3	77.39	7.04	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	149.27	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	106.68	2.52	3.16	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	112.06	6.67	1.33	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	81.95	4.73	3.15	4.73	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	92.13	9.64	3.47	2.89	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	124.61	5.60	2.80	2.97	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	85.57	6.11	5.63	2.57	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	152.11	8.93	5.45	1.74	2.62
small intestine, adult, pool1	10024-101D6	104.99	3.22	2.03	1.31	0.96
small intestine, fetal, donor1	10064-101I1	96.80	2.70	2.21	0.25	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	69.75	0.51	0.00	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	72.63	1.03	1.29	1.29	0.00
somatostatinoma cell line:QGP-1	10781-110G7	186.27	6.70	4.29	3.75	1.34
spinal cord - adult, donor10196	10181-103D1	296.39	13.76	5.74	4.13	3.21
spinal cord, adult, donor10252	10159-103A6	156.13	5.91	3.94	1.18	1.58
spinal cord, adult, donor10258	10369-105F9	90.63	2.08	4.15	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	151.24	4.88	1.83	3.66	0.00
spinal cord, newborn, donor10223	10359-105E8	83.12	10.56	2.30	2.30	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	95.74	3.44	2.24	1.79	0.45
spleen, adult, pool1	10025-101D7	108.26	5.40	2.53	3.63	0.33
spleen, fetal, pool1	10044-101F8	99.08	3.10	3.97	1.75	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.40	2.07	1.04	0.41	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	134.05	3.23	2.47	0.57	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.55	4.19	2.45	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	65.68	1.56	3.91	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	66.63	2.03	2.03	0.45	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	41.94	2.12	2.54	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	57.96	2.54	0.42	2.12	0.42
stomach, fetal, donor1	10062-101H8	291.56	9.61	7.48	3.20	4.27
submaxillary gland, adult	10202-103F4	73.49	1.14	2.28	2.85	0.00
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	93.26	2.28	2.08	0.62	0.83
substantia nigra, adult, donor10258	10371-105G2	169.14	7.24	3.10	7.24	0.00
substantia nigra, newborn, donor10223	10358-105E7	110.93	7.07	7.07	5.65	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	108.44	4.81	1.15	0.92	1.15
temporal lobe, adult, pool1	10031-101E4	323.06	25.43	10.09	7.29	2.46
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	178.07	19.94	9.26	13.53	15.67
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	98.02	10.11	7.47	7.47	3.96
tenocyte, donor1	11763-123H8	49.57	0.35	1.40	0.00	0.00
tenocyte, donor2	11765-123I1	29.76	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	32.99	1.48	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	100.79	7.99	1.87	2.04	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	143.51	5.86	1.54	1.54	0.46
teratocarcinoma cell line:PA-1	10807-111A6	94.54	4.18	0.46	0.62	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	73.38	3.68	1.14	3.55	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	46.89	6.81	1.13	6.43	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	71.65	7.09	2.07	1.85	0.98
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	53.09	4.56	2.61	1.63	0.00
testis, adult, pool1	10026-101D8	100.93	6.01	2.79	1.72	0.97
testis, adult, pool2	10096-102C6	64.05	5.86	2.71	1.35	0.45
thalamus - adult, donor10196	10168-103B6	340.03	3.31	3.31	3.31	1.10
thalamus, adult, donor10252	10154-103A1	209.58	12.19	9.69	2.34	1.72
thalamus, adult, donor10258, tech_rep1	10370-105G1	318.70	3.08	20.02	10.78	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	313.73	21.08	2.14	6.59	0.33
thalamus, newborn, donor10223	10366-105F6	374.53	24.16	5.75	8.05	0.00
throat, adult	10209-103G2	84.64	2.50	2.50	0.25	0.25
throat, fetal, donor1	10061-101H7	94.46	6.40	3.66	2.13	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	50.48	6.16	1.39	2.78	0.20
thymus, adult, pool1	10027-101D9	116.02	15.11	7.06	5.87	3.48
thymus, fetal, pool1	10043-101F7	126.14	10.70	7.48	3.95	3.53
thyroid carcinoma cell line:KHM-5M	10776-110G2	61.43	0.66	0.66	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	69.85	2.37	1.40	0.28	1.12
thyroid, adult, pool1	10028-101E1	73.25	2.99	3.45	1.03	1.59
thyroid, fetal, donor1	10060-101H6	70.93	6.59	5.80	3.16	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	163.22	6.16	3.08	3.08	0.00
tongue, adult	10203-103F5	71.63	1.40	2.09	0.70	0.47
tongue, fetal, donor1	10059-101H5	102.07	2.36	3.94	3.55	0.39
tonsil, adult, pool1	10047-101G2	104.98	4.01	2.70	1.90	1.20
trachea, adult, pool1	10029-101E2	64.62	2.04	2.94	0.74	0.16
trachea, fetal, donor1	10058-101H4	115.79	3.85	5.00	0.77	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	83.61	1.77	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	74.06	3.44	1.52	1.82	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	89.00	5.01	1.88	4.39	0.16
tridermal teratoma cell line:HGRT	10694-109G1	171.23	3.81	11.42	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	64.08	2.20	1.61	0.59	0.42
umbilical cord, fetal, donor1	10057-101H3	68.85	0.00	4.17	2.09	0.00
uterus, adult, pool1	10100-102D1	96.23	3.41	4.10	2.05	0.51
uterus, fetal, donor1	10055-101H1	112.11	2.05	0.51	0.00	2.56
vagina, adult	10204-103F6	117.61	2.58	1.94	2.58	1.94
vein, adult	10191-103E2	119.68	5.04	2.19	2.85	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	30.18	2.40	0.80	0.27	0.80